chr6-132714186-A-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_004666.3(VNN1):​c.-151T>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.407 in 683,500 control chromosomes in the GnomAD database, including 64,653 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.52 ( 23806 hom., cov: 32)
Exomes 𝑓: 0.38 ( 40847 hom. )

Consequence

VNN1
NM_004666.3 upstream_gene

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -2.25

Publications

11 publications found
Variant links:
Genes affected
VNN1 (HGNC:12705): (vanin 1) This gene encodes a member of the vanin family of proteins, which share extensive sequence similarity with each other, and also with biotinidase. The family includes secreted and membrane-associated proteins, a few of which have been reported to participate in hematopoietic cell trafficking. No biotinidase activity has been demonstrated for any of the vanin proteins, however, they possess pantetheinase activity, which may play a role in oxidative-stress response. This protein, like its mouse homolog, is likely a GPI-anchored cell surface molecule. The mouse protein is expressed by the perivascular thymic stromal cells and regulates migration of T-cell progenitors to the thymus. This gene lies in close proximity to, and in the same transcriptional orientation as, two other vanin genes on chromosome 6q23-q24. [provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 6-132714186-A-C is Benign according to our data. Variant chr6-132714186-A-C is described in ClinVar as Benign. ClinVar VariationId is 6230.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.838 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004666.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VNN1
NM_004666.3
MANE Select
c.-151T>G
upstream_gene
N/ANP_004657.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VNN1
ENST00000367928.5
TSL:1 MANE Select
c.-151T>G
upstream_gene
N/AENSP00000356905.4

Frequencies

GnomAD3 genomes
AF:
0.515
AC:
78327
AN:
151988
Hom.:
23755
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.845
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.553
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.382
Gnomad SAS
AF:
0.472
Gnomad FIN
AF:
0.430
Gnomad MID
AF:
0.369
Gnomad NFE
AF:
0.347
Gnomad OTH
AF:
0.508
GnomAD4 exome
AF:
0.376
AC:
199819
AN:
531394
Hom.:
40847
AF XY:
0.378
AC XY:
104347
AN XY:
275692
show subpopulations
African (AFR)
AF:
0.841
AC:
11517
AN:
13696
American (AMR)
AF:
0.563
AC:
10139
AN:
17998
Ashkenazi Jewish (ASJ)
AF:
0.308
AC:
4382
AN:
14236
East Asian (EAS)
AF:
0.371
AC:
11616
AN:
31352
South Asian (SAS)
AF:
0.456
AC:
20703
AN:
45446
European-Finnish (FIN)
AF:
0.409
AC:
12109
AN:
29596
Middle Eastern (MID)
AF:
0.346
AC:
856
AN:
2474
European-Non Finnish (NFE)
AF:
0.336
AC:
117064
AN:
347968
Other (OTH)
AF:
0.399
AC:
11433
AN:
28628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
5627
11255
16882
22510
28137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1672
3344
5016
6688
8360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.516
AC:
78445
AN:
152106
Hom.:
23806
Cov.:
32
AF XY:
0.519
AC XY:
38596
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.845
AC:
35079
AN:
41510
American (AMR)
AF:
0.552
AC:
8436
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
1043
AN:
3468
East Asian (EAS)
AF:
0.383
AC:
1978
AN:
5168
South Asian (SAS)
AF:
0.473
AC:
2284
AN:
4832
European-Finnish (FIN)
AF:
0.430
AC:
4554
AN:
10580
Middle Eastern (MID)
AF:
0.387
AC:
113
AN:
292
European-Non Finnish (NFE)
AF:
0.347
AC:
23594
AN:
67960
Other (OTH)
AF:
0.510
AC:
1079
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1620
3239
4859
6478
8098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
644
1288
1932
2576
3220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.501
Hom.:
4190
Bravo
AF:
0.537
Asia WGS
AF:
0.512
AC:
1784
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
RECLASSIFIED - VNN1 POLYMORPHISM (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.34
DANN
Benign
0.53
PhyloP100
-2.3
PromoterAI
0.12
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4897612; hg19: chr6-133035325; API